EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Neo Cremar Co. Ltd (311390) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Neo Cremar Co. Ltd KRW 4,245, price KRW 2,360, upside +79.9%, quality 56 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Basic Materials · KR

NC Thin data Sep 24, 2026

Neo Cremar Co. Ltd

311390 · KQ

Clearly undervaluedStrong Fair Value upside, but quality is only moderate.

✓Fair value 4,245 KRW · Strongly undervalued (+80%)
!Quality 56/100
✓Healthy Growth (revenue 5y +22.4 %/yr)
!Thin margins · 2.4% net margin (TTM)
✓Low debt · generates free cash flow
·2.12% dividend yield
!Mixed vs. peers (5/10)
!Narrow moat 32/100
!Evidence only low, so the estimate is less certain
!Weak on past: 12 out of 100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

28,919 KRW 2,205 KRW Fair Value 4,245 KRW Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 2,205 KRW – 28,919 KRW · fair‑value band 2,971 KRW – 5,518 KRW · the 2,360 KRW price screens below the 4,245 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.

Follow Neo Cremar Co. in your weekly email

Every Wednesday you see whether Neo Cremar Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Neo Cremar Co., Ltd. manufactures and sells functional food ingredients and additives in South Korea and internationally. The company offers microbiome, functional carbohydrate, functional protein, solubilizable functional ingredients, organic, and other products.

Show more

Neo Cremar Co., Ltd. manufactures and sells functional food ingredients and additives in South Korea and internationally. The company offers microbiome, functional carbohydrate, functional protein, solubilizable functional ingredients, organic, and other products. It also provides functional foods, plant-based meat and cultured meat, customized health functional food, and pharmaceuticals business. Neo Cremar Co., Ltd. was founded in 1999 and is headquartered in Seoul, South Korea.

Stock analysis

Neo Cremar Co. Ltd (311390) currently trades at 2,360 KRW, while our model-based Fair Value estimate is 4,245 KRW, implying the stock looks roughly 44.4% undervalued today.

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 21,615 KRW per share, and 24 of the 24 models we run sit above the 2,360 KRW price.

Bear case: the Asset-Based group reads lowest at 3,917 KRW, and 0 of the 24 models stay below the price. Evidence for this calculation is low.

Scenario range: 2,971 KRW (bear) to 5,518 KRW (bull), the price of 2,360 KRW sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 56/100 (solid quality), in the Basic Materials sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Neo Cremar Co. Ltd reported revenue of 81.9B KRW in FY2025 versus 29.9B KRW in FY2021, a compound +28.7%/yr. Reported net income was 3.0B KRW in FY2025, compounding +12.9%/yr from FY2021.

Key figures

Market cap 29.7B KRW (≈ $21.8M) · P/S ratio 0.37 · Dividend yield 2.1% · Net margin 3.6% · Return on equity 2.9% · Return on assets (EBIT) −0.2% · Operating margin 3.5% · Revenue (TTM) 80.2B KRW.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (medium confidence).

What moves the price

The share trades about 76% below its 52-week high and 7% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at 80%, 311390 screens cheaper than that median.

Fair Value models

Bear 2,971 KRW Fair Value 4,245 KRW Bull 5,518 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 22,966 KRW 34,028 KRW 68,516 KRW 74
EPV 5,990 KRW 6,546 KRW 7,026 KRW 74
Residual Income 4,296 KRW 4,233 KRW 3,749 KRW 74
All 24 models by family
DCF Models
FCF DCF 22,966 KRW 34,028 KRW 68,516 KRW 74
Owner Earnings 15,393 KRW 31,113 KRW 62,900 KRW 69
5Y Revenue Exit 11,426 KRW 15,632 KRW 24,239 KRW 70
5Y EBITDA Exit 11,724 KRW 16,234 KRW 24,978 KRW 72
5Y P/E Exit 10,167 KRW 15,197 KRW 21,287 KRW 68
10Y Revenue Exit 14,872 KRW 24,264 KRW 28,557 KRW 66
10Y EBITDA Exit 15,254 KRW 24,890 KRW 39,769 KRW 65
10Y P/E Exit 14,144 KRW 21,615 KRW 32,142 KRW 61
Earnings-Based
Graham-Dodd 1,614 KRW 11,255 KRW 15,794 KRW 61
Lynch FV 5,815 KRW 8,307 KRW 10,798 KRW 59
PEG = 1.0 5,815 KRW 8,307 KRW 10,798 KRW 55
EPV 5,990 KRW 6,546 KRW 7,026 KRW 74
Multiples
P/E Multiple 2,492 KRW 3,323 KRW 4,153 KRW 63
P/S Multiple 3,026 KRW 4,035 KRW 5,043 KRW 58
P/B Multiple 3,026 KRW 4,035 KRW 5,043 KRW 55
EV/EBIT 5,697 KRW 6,773 KRW 7,849 KRW 66
EV/EBITDA 7,069 KRW 8,602 KRW 10,136 KRW 67
EV/Revenue 6,385 KRW 8,064 KRW 9,743 KRW 54
Asset-Based
NCAV (Graham) 2,923 KRW 3,917 KRW 5,846 KRW 54
Growth DCF
Growth DCF 21,718 KRW 39,109 KRW 67,126 KRW 73
Rev-Margin DCF 12,216 KRW 17,564 KRW 28,934 KRW 69
Economic Profit
Residual Income 4,296 KRW 4,233 KRW 3,749 KRW 74
ROIC Compounder 6,187 KRW 7,635 KRW 9,032 KRW 70
Growth Earnings
Growth-Adj P/E 6,815 KRW 9,735 KRW 12,656 KRW 65

Open the full fair value analysis →

Notify me when 311390 reaches fair value

Put 311390 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 56/100

Of which business quality 58 · Market factors (momentum, volatility) 22

Profitability 27
Margins and returns on capital today
Quality Growth 91
Are margins and returns improving?
Cashflow 87
Earnings quality: real cash, not paper profit
Fin. Strength 59
Balance sheet, leverage, solvency risk
Investment 42
Disciplined investing over empire-building
Low Volatility 59
Calm price path (market factor)
Momentum 9
Price trend over the last 3–12 months (market factor)
52W Momentum 1
Distance to the 52-week high (market factor)
Net Issuance 40
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+103.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+45.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+22.4%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.3%
What shareholders gained per year (last 5 years), in KRW ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in KRW: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+6.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.6%
Dividend (yield on the price)2.1%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5% vs 1%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.4% → 7%
Start year 2020 (pandemic)

Watch 311390, get fair value alerts →

Compare Neo Cremar Co. Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 712 stocks

Beats the industry median on 5/10 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 56 · Above median
Fair Value upside +80% · Top 25%
Profitability
Return on equity (TTM) 3% · Below median
Return on assets 1% · Below median
Net margin (TTM) 2% · Below median
Operating margin (TTM) 3% · Below median
Growth and dividend
Revenue growth −8% · Bottom 25%
Dividend yield (TTM) 2.1% · Above median
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Specialty Chemicals median · lower = cheaper

P/FCF 0.0× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 0
FUTURE (revenue growth)0 · sector 21
PAST (return on equity)12 · sector 23
HEALTH (low debt)99 · sector 95
DIVIDEND (yield)42 · sector 29

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Linde plc LIN $468.14 $441.72 −6%
The Sherwin-Williams Company SHW $326.46 $148.97 −54%
Ecolab Inc ECL $276.72 $96.18 −65%
Air Products and Chemicals, Inc APD $286.97 $122.14 −57%
Nan Ya Plastics Corporation 1303 238.00 TWD 235.25 TWD −1%
Givaudan SA GIVN CHF 3,406 CHF 1,523 −55%
Wanhua Chemical Group 600309 ¥71.60 ¥68.03 −5%
Asian Paints Limited ASIANPAINT ₹2,455 ₹1,479 −40%
PPG Industries, Inc PPG $107.20 $77.06 −28%
DSM-Firmenich AG DSFIR CHF 91.50 CHF 29.27 −68%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Neo Cremar Co. Ltd Fair Value". https://www.fairvalue-calculator.com/stock/311390

Frequently asked questions

Is Neo Cremar Co. Ltd (311390) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 4,245 KRW versus a price of 2,360 KRW, about +80% upside (undervalued).
What is the fair value of 311390?
Our model-based fair value for Neo Cremar Co. Ltd is 4,245 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 2,360 KRW.
What is the quality score of 311390?
Neo Cremar Co. Ltd has a Quality Score of 56/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Neo Cremar Co. Ltd (311390)?
Our model-based price target is the fair value of 4,245 KRW (as of Sep 24, 2026) from 24 valuation models. Cautious scenario 2,971 KRW, optimistic scenario 5,518 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the Neo Cremar Co. Ltd stock forecast for 2026?
Our models put fair value at 4,245 KRW, about +80% upside versus a price of 2,360 KRW (undervalued). Cautious scenario 2,971 KRW, optimistic scenario 5,518 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of Neo Cremar Co. Ltd (311390)?
Neo Cremar Co. Ltd reported trailing-twelve-month revenue of about 80.2B KRW (latest available figure, as of Sep 24, 2026).
Does Neo Cremar Co. Ltd pay a dividend?
Neo Cremar Co. Ltd currently shows a dividend yield of about 2.12% relative to its recent price (as of Sep 24, 2026).
What is the intrinsic value of Neo Cremar Co. Ltd (311390)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Neo Cremar Co. Ltd it is 4,245 KRW per share (as of Sep 24, 2026), against a price of 2,360 KRW. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Neo Cremar Co. Ltd stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 311390 trades below its calculated fair value: price 2,360 KRW, fair value 4,245 KRW, a gap of about +80% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 311390?
No. The price is what the market pays today (2,360 KRW); the fair value is what the company's own numbers justify (4,245 KRW). For Neo Cremar Co. Ltd the two are 1,885 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is Neo Cremar Co. Ltd worth?
The market values Neo Cremar Co. Ltd at about 29.7B KRW (market capitalisation, as of Sep 24, 2026). Per share that is 2,360 KRW; our models calculate a fair value of 4,245 KRW per share.
What do the bullish and bearish scenarios say about 311390?
Our models span a range for Neo Cremar Co. Ltd: cautious scenario 2,971 KRW, base 4,245 KRW, optimistic 5,518 KRW per share (as of Sep 24, 2026, price 2,360 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Neo Cremar Co. Ltd (311390)?
Balance-sheet figures for Neo Cremar Co. Ltd (as of Sep 24, 2026): return on equity 2.9%, debt of 0.03 per unit of equity. They feed the Quality Score of 56/100, which measures business quality independently of the share price.
How far is 311390 from its 52-week high?
Neo Cremar Co. Ltd trades at 2,360 KRW, about 76% below its 52-week high of 10,035 KRW and 7% above the low of 2,205 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 4,245 KRW is for.
Which stocks are comparable to Neo Cremar Co. Ltd?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Neo Cremar Co. Ltd stock attractive at the current price?
The data as of Sep 24, 2026: price 2,360 KRW, calculated fair value 4,245 KRW (+80%), Quality Score 56/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 311390 calculated?
We run Neo Cremar Co. Ltd through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 4,245 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.0 % above its aggregate fair value. Neo Cremar Co. Ltd currently trades 80 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Neo Cremar Co. Ltd (311390)?
The closing price on Sep 23, 2026 was 2,360 KRW. Our model-based fair value is 4,245 KRW, about +80% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Neo Cremar Co. Ltd right now?
The price is below even our cautious bear case (2,971 KRW). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (56/100) at a price below fair value, the discount is the argument here, not the business quality. A fairly wide model range (2,971 KRW to 5,518 KRW) leaves room in how you read the outcome.

Key figures of Neo Cremar Co. Ltd

How large is the market capitalisation of Neo Cremar Co. Ltd (311390)?
The market capitalisation of Neo Cremar Co. Ltd is 29.7B KRW (≈ $21.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Neo Cremar Co. Ltd (311390)?
The price-to-sales ratio of Neo Cremar Co. Ltd is 0.37 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of Neo Cremar Co. Ltd (311390)?
The dividend yield of Neo Cremar Co. Ltd is 2.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Neo Cremar Co. Ltd (311390)?
The net margin of Neo Cremar Co. Ltd is 3.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Neo Cremar Co. Ltd (311390)?
The return on equity (ROE) of Neo Cremar Co. Ltd is 2.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Neo Cremar Co. Ltd (311390)?
On an EBIT basis the return on assets of Neo Cremar Co. Ltd is −0.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Neo Cremar Co. Ltd (311390)?
The operating margin of Neo Cremar Co. Ltd is 3.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Neo Cremar Co. Ltd (311390)?
Revenue at Neo Cremar Co. Ltd is growing −8.2% versus a year earlier (3y avg +45.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Neo Cremar Co. Ltd (311390)?
Earnings per share at Neo Cremar Co. Ltd are growing −88.6% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Neo Cremar Co. Ltd (311390) generate?
The free cash flow of Neo Cremar Co. Ltd is 14.9B KRW (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Neo Cremar Co. Ltd in the live analysis

One click puts Neo Cremar Co. Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.